I 

116TH CONGRESS 

1ST SESSION H. R. 2482 

To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) 

to eliminate the separate registration requirement for dispensing narcotic 

drugs in schedule III, IV, or V (such as buprenorphine) for maintenance 

or detoxification treatment, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 2, 2019 

Mr. TONKO (for himself, Mr. LUJA ́N, Mr. DELGADO, Mr. BUDD, Ms. 

STEFANIK, and Mr. TURNER) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to 

the Committees on the Judiciary, and Ways and Means, for a period to 

be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee 

concerned 

A BILL 

To amend section 303(g) of the Controlled Substances Act 

(21 U.S.C. 823(g)) to eliminate the separate registration 

requirement for dispensing narcotic drugs in schedule 

III, IV, or V (such as buprenorphine) for maintenance 

or detoxification treatment, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Mainstreaming Addic5 tion Treatment Act of 2019’’. 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•HR 2482 IH

1 SEC. 2. ELIMINATING SEPARATE REGISTRATION REQUIRE2 MENT FOR DISPENSING NARCOTIC DRUGS IN 

3 SCHEDULE III, IV, AND V FOR MAINTENANCE 

4 OR DETOXIFICATION TREATMENT. 

5 (a) IN GENERAL.—Section 303 of the Controlled 

6 Substances Act (21 U.S.C. 823) is amended— 

7 (1) by striking paragraph (2) of subsection (g); 

8 and 

9 (2) in subsection (g), as amended— 

10 (A) by striking ‘‘(g)(1) Except as provided 

11 in paragraph (2), practitioners who dispense 

12 narcotic drugs to individuals for maintenance 

13 treatment or detoxification treatment’’ and in14 serting ‘‘(g) Practitioners who dispense narcotic 

15 drugs (other than narcotic drugs in schedule 

16 III, IV, or V) to individuals for maintenance 

17 treatment or detoxification treatment’’; 

18 (B) by redesignating subparagraphs (A), 

19 (B), and (C) as paragraphs (1), (2), and (3), 

20 respectively; and 

21 (C) in paragraph (2), as redesignated, by 

22 redesignating clauses (i) and (ii) as subpara23 graphs (A) and (B), respectively. 

24 (b) CONFORMING CHANGES.— 

25 (1) Subsections (a) and (d)(1) of section 304 of 

26 the Controlled Substances Act (21 U.S.C. 824) are 


pamtmann on DSKBFK8HB2PROD with BILLS
3 

•HR 2482 IH

1 amended by striking ‘‘303(g)(1)’’ each place it ap2 pears and inserting ‘‘303(g)’’. 

3 (2) Section 309A(a)(2) of the Controlled Sub4 stances Act (21 U.S.C. 829a) is amended— 

5 (A) in the matter preceding subparagraph 

6 (A), by striking ‘‘the controlled substance is to 

7 be administered for the purpose of maintenance 

8 or detoxification treatment under section 

9 303(g)(2)’’ and inserting ‘‘the controlled sub10 stance is a narcotic drug in schedule III, IV, or 

11 V to be administered for the purpose of mainte12 nance or detoxification treatment’’; and 

13 (B) by striking ‘‘and—’’ and all that fol14 lows through ‘‘is to be administered by injection 

15 or implantation;’’ and inserting ‘‘and is to be 

16 administered by injection or implantation;’’. 

17 (3) Section 520E–4(c) of the Public Health 

18 Service Act (42 U.S.C. 290bb–36d(c)) is amended 

19 by striking ‘‘information on any qualified practi20 tioner that is certified to prescribe medication for 

21 opioid dependency under section 303(g)(2)(B) of the 

22 Controlled Substances Act’’ and inserting ‘‘informa23 tion on any practitioner who prescribes narcotic 

24 drugs in schedule III, IV, or V of section 202 of the 


pamtmann on DSKBFK8HB2PROD with BILLS
4 

•HR 2482 IH

1 Controlled Substances Act for the purpose of main2 tenance or detoxification treatment’’. 

3 (4) Section 544(a)(3) of the Public Health 

4 Service Act (42 U.S.C. 290dd–3) is amended by 

5 striking ‘‘any practitioner dispensing narcotic drugs 

6 pursuant to section 303(g) of the Controlled Sub7 stances Act’’ and inserting ‘‘any practitioner dis8 pensing narcotic drugs for the purpose of mainte9 nance or detoxification treatment’’. 

10 (5) Section 1833(bb)(3)(B) of the Social Secu11 rity Act (42 U.S.C. 1395l(bb)(3)(B)) is amended by 

12 striking ‘‘first receives a waiver under section 303(g) 

13 of the Controlled Substances Act on or after Janu14 ary 1, 2019’’ and inserting ‘‘first begins prescribing 

15 narcotic drugs in schedule III, IV, or V of section 

16 202 of the Controlled Substances Act for the pur17 pose of maintenance or detoxification treatment on 

18 or after January 1, 2019’’. 

19 (6) Section 1834(o)(3)(C)(ii) of the Social Se20 curity Act (42 U.S.C. 1395m(o)(3)(C)(ii)) is amend21 ed by striking ‘‘first receives a waiver under section 

22 303(g) of the Controlled Substances Act on or after 

23 January 1, 2019’’ and inserting ‘‘first begins pre24 scribing narcotic drugs in schedule III, IV, or V of 

25 section 202 of the Controlled Substances Act for the 


pamtmann on DSKBFK8HB2PROD with BILLS
5 

•HR 2482 IH

1 purpose of maintenance or detoxification treatment 

2 on or after January 1, 2019’’. 

3 (7) Section 1866F(c)(3) of the Social Security 

4 Act (42 U.S.C. 1395cc–6(c)(3)) is amended— 

5 (A) in subparagraph (A), by inserting 

6 ‘‘and’’ at the end; 

7 (B) in subparagraph (B), by striking ‘‘; 

8 and’’ and inserting a period; and 

9 (C) by striking subparagraph (C). 

10 (8) Section 1903(aa)(2)(C) of the Social Secu11 rity Act (42 U.S.C. 1396b(aa)(2)(C)) is amended— 

12 (A) in clause (i), by inserting ‘‘and’’ at the 

13 end; and 

14 (B) by striking clause (ii). 

15 SEC. 3. NATIONAL EDUCATION CAMPAIGN. 

16 (a) IN GENERAL.—The Secretary of Health and 

17 Human Services, acting through the Assistant Secretary 

18 for Mental Health and Substance Use, shall conduct a na19 tional campaign to educate practitioners with respect to 

20 the elimination of the separate registration requirement 

21 under section 303(g) of the Controlled Substances Act (21 

22 U.S.C. 823(g)), as in effect on the day before the date 

23 of enactment of this Act, for dispensing narcotic drugs in 

24 schedule III, IV, and V for maintenance or detoxification 

25 treatment. 


pamtmann on DSKBFK8HB2PROD with BILLS
6 

•HR 2482 IH

1 (b) REQUIRED COMPONENTS.—The national edu2 cation campaign under subsection (a) shall— 

3 (1) encourage practitioners to integrate sub4 stance use treatment into their practices; and 

5 (2) include education on publicly available edu6 cational resources and training modules that can as7 sist practitioners in treating patients with a sub8 stance use disorder. 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS